Emergency Department Treatment for Shingles (Herpes Zoster)
Start oral antiviral therapy immediately—within 72 hours of rash onset—with valacyclovir 1000 mg three times daily for 7 days, famciclovir 500 mg three times daily for 7 days, or acyclovir 800 mg five times daily for 7 days, combined with aggressive pain management using gabapentin or pregabalin for acute pain control. 1, 2, 3
Immediate Assessment Priorities
When a patient presents to the ED with suspected shingles, rapidly assess:
- Timing of rash onset: Antiviral efficacy is highest when started within 72 hours of rash appearance
- Dermatomal distribution: Unilateral vesicular rash following a dermatome
- High-risk features requiring urgent intervention:
- Ophthalmic involvement (V1 distribution, Hutchinson's sign)
- Immunocompromised status (HIV, transplant recipients, chemotherapy patients)
- Disseminated disease (lesions beyond primary and adjacent dermatomes)
- Facial involvement near ears (risk of Ramsay Hunt syndrome)
Antiviral Therapy Selection
First-line oral antivirals (all equally effective when given appropriately):
- Valacyclovir 1000 mg PO three times daily × 7 days (preferred for convenience—better bioavailability than acyclovir)
- Famciclovir 500 mg PO three times daily × 7 days (alternative with similar efficacy)
- Acyclovir 800 mg PO five times daily × 7 days (requires more frequent dosing, less convenient)
Special Situations Requiring IV Therapy
Switch to IV acyclovir 10 mg/kg every 8 hours for:
- Immunocompromised patients (HIV, transplant recipients, active chemotherapy)
- Disseminated herpes zoster
- Ophthalmic zoster with vision-threatening complications
- Inability to tolerate oral medications
- Severe disease with extensive skin involvement
Pain Management Strategy
Acute pain control is critical to prevent progression to postherpetic neuralgia (PHN):
Immediate ED Pain Management:
- Gabapentin: Start 300 mg PO three times daily, titrate up to 900-1800 mg/day divided three times daily
- Pregabalin: Alternative at 75-150 mg PO twice daily
- Opioids: Short-term use (3-7 days) for severe acute pain—oxycodone 5-10 mg every 4-6 hours as needed
- NSAIDs/Acetaminophen: Adjunctive for mild-moderate pain
Avoid corticosteroids in the ED setting—while they may reduce short-term pain, they increase risk of serious adverse effects, especially in older adults, without reducing PHN incidence. 6
Critical Pitfalls to Avoid
- Do not delay antiviral therapy waiting for laboratory confirmation—diagnosis is clinical
- Do not use topical antivirals alone—they are ineffective for systemic VZV infection
- Do not discharge immunocompromised patients on oral therapy—they require IV acyclovir and admission consideration
- Do not miss ophthalmic involvement—requires immediate ophthalmology consultation and IV acyclovir
Disposition and Follow-up
Discharge home if:
- Immunocompetent
- No ophthalmic/disseminated involvement
- Able to tolerate oral medications
- Adequate pain control achieved
- Reliable for 48-72 hour follow-up
Admit or arrange urgent consultation if:
- Immunocompromised status
- Ophthalmic zoster (ophthalmology)
- Disseminated disease
- Severe pain uncontrolled with oral medications
- Ramsay Hunt syndrome (ENT consultation)
ED discharge instructions must include:
- Complete 7-day antiviral course even if symptoms improve
- Pain medication titration plan with specific gabapentin/pregabalin escalation schedule
- Warning signs requiring immediate return: vision changes, severe headache, altered mental status, spreading rash
- Follow-up within 48-72 hours with primary care or dermatology